A study on the effect of add-on rosiglitazone on the anklebrachial pressure index of patients with type 2 diabetes mellitus in hospital Universiti Sains malaysia
Background Rosiglitazone, an oral hypoglycaemic agent of the thiazolidinedione group is used for Type 2 Diabetes treatment. Research has shown that this medication, being a peroxisome proliferator activator receptor-gamma agonist has effects beyond glycaemic control alone. Apart from improving in...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 語言: | English |
| 出版: |
2007
|
| 主題: | |
| 在線閱讀: | http://eprints.usm.my/48443/1/Dr.%20NAZRI%20MUSTAFFA.pdf http://eprints.usm.my/48443/ |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|